Robot-assisted radical cystectomy with intracorporeal reconstruction of urinary diversion by mechanical stapler: prospective evaluation of early and late complications.

complications intracorporeal urinary diversion mechanical stapler perioperative outcomes robot-assisted radical cystectomy

Journal

Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127

Informations de publication

Date de publication:
2023
Historique:
received: 02 02 2023
accepted: 22 05 2023
medline: 29 6 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: epublish

Résumé

Radical cystectomy with pelvic lymph node dissection is the gold standard treatment for non-metastatic muscle-invasive bladder cancer and high-risk non-muscle-invasive bladder cancer. For years, the traditional open surgery approach was the only viable option. The widespread of robotic surgery led to its employment also in radical cystectomy to reduce complication rates and improve functional outcomes. Regardless of the type of approach, radical cystectomy is a procedure with high morbidity and not negligible mortality. Data available in the literature show how the use of staplers can offer valid functional outcomes, with an acceptable rate of complications shortening the operative time. The aim of our study was to describe the perioperative outcomes and complications associated with robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD) using a mechanical stapler. From January 2015 to May 2021, we enrolled patients who underwent RARC with pelvic node dissection and stapled ICUD (ileal conduit or ileal Y-shaped neobladder according to the Perugia ileal neobladder) in our high-volume center. Demographic features, perioperative outcomes and early (≤30 days) and late (>90 days) post-operative complications according to the Clavien-Dindo classification, were recorded for each patient. We also analyzed the potential linear correlation between demographic, pre-operative as well as operative features and the risk of post-operative complications. Overall, 112 patients who underwent RARC with ICUD were included with a minimum follow-up of 12 months. Intracorporeal Perugia ileal neobladder was performed in 74.1% of cases while ileal conduit was performed in 25.9%. The mean operative time, estimated intraoperative blood loss, and LOS were 289.1 ± 59.7 min, 390.6 ± 186.2 ml, and 17.5 ± 9.8 days, respectively. Early minor and major complications accounted for 26.7% and 10.8%, respectively. Overall late complications were 40.2%. The late most common complications were hydronephrosis (11.6%) and urinary tract infections (20.5%). Stone reservoir formation occurred in 2.7% of patients. Major complications occurred in 5.4%. In the sub-analysis, the mean operative time and the estimated blood loss improved significantly from the first 56 procedures to the last ones. RARC with ICUD performed by mechanical stapler is a safe and effective technique. Stapled Y-shaped neobladder did not increase the complication rate.

Identifiants

pubmed: 37383384
doi: 10.3389/fsurg.2023.1157684
pmc: PMC10293791
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1157684

Informations de copyright

© 2023 Cochetti, Paladini, Del Zingaro, Ciarletti, Pastore, Massa, De Angelis and Mearini.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Eur Urol. 2012 Nov;62(5):806-13
pubmed: 22705382
Open Med (Wars). 2019 Sep 15;14:711-718
pubmed: 31572804
Scand J Urol. 2018 Aug;52(4):244-248
pubmed: 30103644
J Urol. 2006 Mar;175(3 Pt 1):886-9; discussion 889-90
pubmed: 16469572
Urol Oncol. 2017 Dec;35(12):674.e19-674.e24
pubmed: 28888400
J Urol. 2021 Apr;205(4):1119-1125
pubmed: 33249976
World J Urol. 2018 Jul;36(7):1079-1084
pubmed: 29500511
Turk J Urol. 2020 Mar 14;:
pubmed: 32301693
J Urol. 2022 May;207(5):982-992
pubmed: 34986007
Int J Urol. 2020 Mar;27(3):194-205
pubmed: 31981379
Eur Urol. 2015 Mar;67(3):423-31
pubmed: 25595099
BJU Int. 2014 Jul;114(1):46-55
pubmed: 24219110
Eur Urol. 2011 Feb;59(2):213-8
pubmed: 21109343
Urology. 2012 Dec;80(6):1176-80
pubmed: 23040727
World J Urol. 2023 Mar;41(3):739-746
pubmed: 36847812
Eur J Surg Oncol. 2016 Mar;42(3):412-8
pubmed: 26746089
Transl Androl Urol. 2021 May;10(5):2216-2232
pubmed: 34159105
J Thorac Dis. 2018 Aug;10(8):4838-4848
pubmed: 30233857
Urology. 2001 Nov;58(5):707-11
pubmed: 11711346
World J Urol. 2011 Feb;29(1):73-7
pubmed: 21132553
World J Urol. 2012 Dec;30(6):747-52
pubmed: 23142825
J Endourol. 2017 Jan;31(1):32-37
pubmed: 27824258
J Urol. 2023 Mar;209(3):460-461
pubmed: 36573931
Cent European J Urol. 2022;75(2):135-144
pubmed: 35937656
Indian J Urol. 2014 Jul;30(3):314-7
pubmed: 25097319
Urol Oncol. 2011 Jul-Aug;29(4):366-71
pubmed: 21592881
Urology. 2000 Dec 20;56(6):899-905
pubmed: 11113727
Eur Urol. 2013 Jul;64(1):52-7
pubmed: 23380164
Eur Urol Focus. 2022 Mar;8(2):465-471
pubmed: 33712389
Urology. 2011 Feb;77(2):357-62
pubmed: 20828801
Int J Urol. 2021 May;28(5):493-501
pubmed: 33768583
Curr Oncol. 2021 Oct 13;28(5):4109-4117
pubmed: 34677266
World J Urol. 2006 Aug;24(3):296-304
pubmed: 16518661
Eur J Surg Oncol. 2022 Mar;48(3):694-702
pubmed: 34949495
Front Oncol. 2022 May 05;12:895460
pubmed: 35600337
Eur Urol. 2018 Jun;73(6):934-940
pubmed: 27780643
Minerva Urol Nephrol. 2021 Dec;73(6):754-762
pubmed: 33016028
Scand J Urol. 2021 Feb;55(1):41-45
pubmed: 33169655
Urol Oncol. 2022 Mar;40(3):105.e11-105.e18
pubmed: 34911649
Urology. 1997 Jun;49(6):822-30
pubmed: 9187685
Arab J Urol. 2020 Nov 2;19(1):9-23
pubmed: 33763244
J Urol. 2015 Mar;193(3):891-6
pubmed: 25234300
Eur Urol. 2010 Aug;58(2):197-202
pubmed: 20434830
J Endourol. 2022 Jun;36(6):770-784
pubmed: 35156854
Biomed Res Int. 2015;2015:154392
pubmed: 26819948
BJU Int. 2010 Feb;105(4):520-7
pubmed: 19735257

Auteurs

Giovanni Cochetti (G)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Alessio Paladini (A)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Michele Del Zingaro (M)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Sara Ciarletti (S)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Francesca Pastore (F)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Guido Massa (G)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Lorenzo De Angelis (L)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Ettore Mearini (E)

Urology Clinic, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Classifications MeSH